Kim Catherine, Redberg Rita F, Pavlic Tiana, Eagle Kim A
Division of General Internal Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Clin Cardiol. 2007 Oct;30(10):491-5. doi: 10.1002/clc.20000.
Gender differences exist in outcomes, particularly early mortality, for percutaneous interventions (PCI) and coronary artery bypass graft surgery (CABG). Better understanding of this issue may target areas for improvement for all patients undergoing revascularization. Therefore, we summarized the evidence on gender differences in PCI and CABG outcomes, particularly early mortality, and mediators of this difference. Using the key terms "women" or "gender," "revascularization," "coronary artery bypass," "angioplasty," "stent," and "coronary intervention," we searched MEDLINE from 1985 to 2005 for all randomized controlled trials (RCTs) and registries reporting outcomes by gender. Bibliographies and the Web sites of cardiology conferences were also reviewed. The literature was examined to identify gender differences in outcomes and mediators of these differences. We identified 23 studies reporting outcomes by gender for CABG and 48 studies reporting outcomes by gender for PCI. The majority of studies noted greater in-hospital mortality in women than in men, with mortality differences resolving with longer follow-up. Early mortality differences were reduced but not consistently eliminated after adjustment for comorbidities, procedural characteristics, and body habitus. Power to detect gender differences after multivariate adjustment was limited by declining mortality rates and small sample size. Gender was an independent risk factor for complications after both CABG and PCI. Women experience greater complications and early mortality after revascularization. Future exploration is needed of gender differences in quality of care and benefit from combinations of stenting and antiplatelet, and anticoagulant medications in order to optimize treatment.
经皮介入治疗(PCI)和冠状动脉旁路移植术(CABG)的治疗结果存在性别差异,尤其是早期死亡率方面。更好地理解这一问题可能有助于确定所有接受血运重建治疗患者的改进方向。因此,我们总结了PCI和CABG治疗结果,尤其是早期死亡率方面的性别差异证据,以及造成这种差异的影响因素。我们使用关键词“女性”或“性别”、“血运重建”、“冠状动脉旁路移植术”、“血管成形术”、“支架”和“冠状动脉介入治疗”,检索了1985年至2005年期间MEDLINE数据库中所有按性别报告治疗结果的随机对照试验(RCT)和登记研究。我们还查阅了心脏病学会议的参考文献和网站。对相关文献进行审查,以确定治疗结果的性别差异以及造成这些差异的影响因素。我们确定了23项按性别报告CABG治疗结果的研究,以及48项按性别报告PCI治疗结果的研究。大多数研究指出,女性住院死亡率高于男性,随着随访时间延长,死亡率差异逐渐消失。在对合并症、手术特征和身体状况进行调整后,早期死亡率差异有所减小,但并未完全消除。多变量调整后检测性别差异的效能受到死亡率下降和样本量较小的限制。性别是CABG和PCI术后并发症的独立危险因素。女性在血运重建后会经历更多并发症和早期死亡。未来需要探索护理质量方面的性别差异,以及支架置入与抗血小板和抗凝药物联合使用的获益情况,以便优化治疗。